These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6073602)
1. An interview with Dr. James L. Goddard. Callahan B Hosp Prog; 1967 Sep; 48(9):62-6. PubMed ID: 6073602 [No Abstract] [Full Text] [Related]
2. James L. Goddard, M.D., Former FDA commissioner, statement to Senate Subcommittee on Health. Goddard JL J Tenn Med Assoc; 1973 Apr; 66(4):382-3. PubMed ID: 4735311 [No Abstract] [Full Text] [Related]
3. Hospital pharmacy program for reporting adverse drug reactions. Jacinto MS; Kleinmann K Am J Hosp Pharm; 1983 Mar; 40(3):444-5. PubMed ID: 6846353 [No Abstract] [Full Text] [Related]
4. Assessment of adverse drug reactions in the hospital setting: considerations. Jones JK Hosp Formul; 1979 Aug; 14(8):769-72, 774, 776. PubMed ID: 10243167 [No Abstract] [Full Text] [Related]
5. Reporting adverse drug reaction in a small hospital. Magee PE; Garrison TJ Hospitals; 1976 Jan; 50(2):63-4, 66-7. PubMed ID: 1245331 [No Abstract] [Full Text] [Related]
6. Developing an adverse drug reaction reporting program. Nelson RW; Shane R Am J Hosp Pharm; 1983 Mar; 40(3):445-6. PubMed ID: 6846354 [No Abstract] [Full Text] [Related]
7. Modern pharmacy practice. N.A.S-N.R.C. reports efficacy of drugs released before 1962. Bowles GC Mod Hosp; 1970 Jul; 115(1):108. PubMed ID: 5468047 [No Abstract] [Full Text] [Related]
8. ASHP guidelines for the use of investigational drugs in institutions. Am J Hosp Pharm; 1983 Mar; 40(3):449-51. PubMed ID: 6846357 [No Abstract] [Full Text] [Related]
15. Comprehensive pharmacy-based investigational drug service. Benfell K; Powell SH; Kaul AF Am J Hosp Pharm; 1983 Jan; 40(1):64-7. PubMed ID: 6823990 [No Abstract] [Full Text] [Related]
16. Improving and enforcing compounding pharmacy practices to protect patients. Pegues DA Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363 [No Abstract] [Full Text] [Related]
17. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view. Fink JL Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540 [No Abstract] [Full Text] [Related]
18. Legal implications of preparing and dispensing approved drugs for unlabeled indications. Podell LB Am J Hosp Pharm; 1983 Jan; 40(1):111-3. PubMed ID: 6823981 [TBL] [Abstract][Full Text] [Related]
19. Drug purchasing considerations. Mehl B Hosp Pharm; 1988 Oct; 23(10):913, 916-7. PubMed ID: 10290113 [No Abstract] [Full Text] [Related]
20. Public Law 89-74 (H.R. 2). Drug Abuse Control Amendments of 1965 as applicable to hospitals and nursing homes. Archambault GF Am J Hosp Pharm; 1965 Dec; 22(12):674-5. PubMed ID: 5843836 [No Abstract] [Full Text] [Related] [Next] [New Search]